262 related articles for article (PubMed ID: 33541586)
21. Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids.
Sadick M; Richers J; Tuschy B; Schad LR; Schoenberg SO; Zöllner FG
Magn Reson Imaging; 2019 Jun; 59():31-38. PubMed ID: 30807812
[TBL] [Abstract][Full Text] [Related]
22. MR-guided focused ultrasound for the treatment of uterine fibroids.
Hesley GK; Gorny KR; Woodrum DA
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):5-13. PubMed ID: 22453202
[TBL] [Abstract][Full Text] [Related]
23. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy.
Verpalen IM; de Boer JP; Linstra M; Pol RLI; Nijholt IM; Moonen CTW; Bartels LW; Franx A; Boomsma MF; Braat MNG
Eur Radiol; 2020 May; 30(5):2473-2482. PubMed ID: 32040725
[TBL] [Abstract][Full Text] [Related]
24. Alternative therapies in management of leiomyomas.
Patel A; Malik M; Britten J; Cox J; Catherino WH
Fertil Steril; 2014 Sep; 102(3):649-55. PubMed ID: 25106764
[TBL] [Abstract][Full Text] [Related]
25. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation.
Zhao WP; Chen JY; Chen WZ
Ultrasound Med Biol; 2015 Feb; 41(2):423-31. PubMed ID: 25542494
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas.
Taran FA; Tempany CM; Regan L; Inbar Y; Revel A; Stewart EA;
Ultrasound Obstet Gynecol; 2009 Nov; 34(5):572-8. PubMed ID: 19852046
[TBL] [Abstract][Full Text] [Related]
27. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre.
Mindjuk I; Trumm CG; Herzog P; Stahl R; Matzko M
Eur Radiol; 2015 May; 25(5):1317-28. PubMed ID: 25510445
[TBL] [Abstract][Full Text] [Related]
28. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice.
Ruhnke H; Eckey T; Bohlmann MK; Beldoch MP; Neumann A; Agic A; Hägele J; Diedrich K; Barkhausen J; Hunold P
Rofo; 2013 Oct; 185(10):983-91. PubMed ID: 24490234
[TBL] [Abstract][Full Text] [Related]
29. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.
Pron G
Ont Health Technol Assess Ser; 2015; 15(4):1-86. PubMed ID: 26357530
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.
Cain-Nielsen AH; Moriarty JP; Stewart EA; Borah BJ
J Comp Eff Res; 2014 Sep; 3(5):503-14. PubMed ID: 24878319
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
[TBL] [Abstract][Full Text] [Related]
32. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
33. High-intensity focused ultrasound therapy.
Cheung VYT
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():74-83. PubMed ID: 29074037
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements, a systematic review.
Gizzo S; Saccardi C; Patrelli TS; Ancona E; Noventa M; Fagherazzi S; Mozzanega B; D'Antona D; Nardelli GB
Reprod Sci; 2014 Apr; 21(4):465-76. PubMed ID: 23868442
[TBL] [Abstract][Full Text] [Related]
35. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
Kim YS; Kim JH; Rhim H; Lim HK; Keserci B; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH
Radiology; 2012 May; 263(2):600-9. PubMed ID: 22403170
[TBL] [Abstract][Full Text] [Related]
36. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids.
Quinn SD; Vedelago J; Gedroyc W; Regan L
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():247-51. PubMed ID: 25445107
[TBL] [Abstract][Full Text] [Related]
37. Role of contrast-enhanced ultrasonography in MR-guided focused ultrasound ablation on uterus fibroids: lesion selection and assessment of ablative effects.
Luo W; Zhang PD; Yang X; Zheng JM; Liu Y; Tang X; Liu HJ; Ding L; Pang LN; Zhou XD; Liu LW; Zheng MW
Eur Radiol; 2022 Mar; 32(3):2110-2119. PubMed ID: 34751794
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
Park H; Yoon SW
Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin and Misoprostol With Diclofenac in the Preparation for Magnetic Resonance-Guided High-Intensity Ultrasound Treatment of Symptomatic Uterine Fibroids: A Prospective Cohort Study.
Łoziński T; Ludwin A; Filipowska J; Zgliczyńska M; Węgrzyn P; Kluz T; Ciebiera M
Ultrasound Med Biol; 2021 Jun; 47(6):1573-1585. PubMed ID: 33785226
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility.
Bouwsma EV; Gorny KR; Hesley GK; Jensen JR; Peterson LG; Stewart EA
Fertil Steril; 2011 Jul; 96(1):e9-e12. PubMed ID: 21570071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
